BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed DMAC catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:d5b11ba778c65057963d@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:DMAC P2/P3 readout (est.): ReMEDy2
DESCRIPTION:Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)\nNCT05065216
  | PHASE2/PHASE3 | RECRUITING | sponsor: DiaMedica Therapeutics Inc\nPrima
 ry completion date (ESTIMATED)\; top-line results usually follow later.\nD
 ate precision: month (shown on the first day)\nTicker DMAC (confidence 0.9
 )\nSource: https://clinicaltrials.gov/study/NCT05065216\nScheduling/refere
 nce data from public records\; dates can move. Not investment\, legal or m
 edical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT05065216
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
